keyword
https://read.qxmd.com/read/37832654/illuminating-htlv-1-induced-adult-t-cell-leukemia-lymphoma-transcriptomic-signature-a-systems-virology-approach
#21
JOURNAL ARTICLE
Mohammad-Moien Forghani-Ramandi, Behnam Mostafavi, Atefeh Bahavar, Maryam Dehghankar, Zeinab Siami, Sayed-Hamidreza Mozhgani
BACKGROUND: Adult T-cell leukemia/lymphoma (ATLL) is a poor prognosis malignancy of peripheral T-cells caused by human T-cell leukemia virus type 1 (HTLV-1). The low survival rates observed in the patients are the result of the lack of sufficient knowledge about the disease pathogenesis. METHODS: In the present study, we first identified differentially expressed genes in ATLL patients and the cellular signaling pathways affected by them. Then, genes of these pathways were subjected to more comprehensive evaluations, including WGCNA and module validation studies on five external datasets...
October 11, 2023: Virus Research
https://read.qxmd.com/read/37811765/identification-of-naturally-occurring-compounds-as-alternatives-to-radiation-therapy-for-treatment-of-small-cell-lung-cancer
#22
JOURNAL ARTICLE
M Shivapriya Pingali, Anirudh Singh, Ananya Anurag Anand, Sachin Kumar Gupta, Amaresh Kumar Sahoo, Pritish Kumar Varadwaj, Sintu Kumar Samanta
Radiation resistance is one of the major problems in the treatment of small cell lung cancer (SCLC). Most of these patients are given radiation as first-line treatment and it was observed that the initial response in these patients is very good. However, they show relapse in a few months which is also associated with resistance to treatment. Thus, targeting the mechanism by which these cells develop resistance could be an important strategy to improve the survival chances of these patients. From the RNA-Seq data analysis, it was identified that CHEK1 gene was overexpressed...
October 9, 2023: Journal of Biomolecular Structure & Dynamics
https://read.qxmd.com/read/37805421/-prognostic-significance-and-immune-cell-infiltration-analysis-of-differentially-expressed-genes-in-malignant-pleural-mesothelioma
#23
JOURNAL ARTICLE
N Wang, Q N Zhao, Q Yuan, B L Zhu, W Wu
Objective: To explore and analyze differential expressed genes in malignant pleural mesothelioma (MPM) by bioinformatics method, and to study their prognostic value in MPM and their potential role in immunotherapy. Methods: In January 2022, the dataset GSE51024 was downloaded from the GEO database, and MPM (55 cases) and normal tissue (41 cases) samples were obtained. Using R software and HMDD and miRNet database, MPM-related differential genes were screened and co-expressed genes were identified. Co-expressed genes were enriched and functionally annotated, and protein-protein interaction (PPI) networks were constructed and key genes were identified using the STRING database and Cytoscape software...
September 20, 2023: Chinese Journal of Industrial Hygiene and Occupational Diseases
https://read.qxmd.com/read/37793997/identification-of-formononetin-as-the-active-compound-of-cr-sr-in-hepatocellular-carcinoma-treatment-an-integrated-approach-combining-network-pharmacology-and-weighted-gene-co-expression-networks
#24
JOURNAL ARTICLE
Chun Li, Yuxin Xie, Shaoyu Hu, Hong Yu, Yunke Xu, Hongping Shen, Yuan Yuan, Long Gu, Bangming Pu
Hepatocellular carcinoma (HCC) is a life-threatening disease for which there is no cure. Traditional Chinese medicine is a treasure trove of Medicinals that has been used for thousands of years. In China, the traditional herb pair, Curcumae Rhizoma and Sparganii Rhizoma (CR-SR) represent a classic herbal combination used for the treatment of HCC. However, the drug targets and pharmacological mechanism of action of CR-SR in the treatment of HCC are unclear. To address this, we screened the active components and drug targets of CR-SR from the Traditional Chinese Medicine Systems Pharmacology (TCMSP) database and a high-throughput experiment- and reference-guided database of traditional Chinese medicines (HERB database)...
October 4, 2023: Chemical Biology & Drug Design
https://read.qxmd.com/read/37761360/the-genomic-landscape-of-colorectal-cancer-in-the-saudi-arabian-population-using-a-comprehensive-genomic-panel
#25
JOURNAL ARTICLE
Ebtehal Alsolme, Saleh Alqahtani, Musa Fageeh, Duna Barakeh, Nitesh K Sharma, Serghei Mangul, Heather A Robinson, Amany Fathaddin, Charlotte A E Hauser, Malak Abedalthagafi
PURPOSE: Next-generation sequencing (NGS) technology detects specific mutations that can provide treatment opportunities for colorectal cancer (CRC) patients. PATIENTS AND METHODS: We analyzed the mutation frequencies of common actionable genes and their association with clinicopathological characteristics and oncologic outcomes using targeted NGS in 107 Saudi Arabian patients without a family history of CRC. RESULTS: Approximately 98% of patients had genetic alterations...
September 19, 2023: Diagnostics
https://read.qxmd.com/read/37715382/bioinformatic-analysis-of-chek1-as-a-marker-of-glomerular-epithelial-cell-injury-in-diabetic-nephropathy
#26
JOURNAL ARTICLE
Dan Wang, Yuejuan Du, Ran Huang, Fang Liu, Pu Wang
Diabetic nephropathy (DN) is considered to be a kidney disease caused by diabetes. In recent years, the incidence of DN has been on the rise, which is also a major challenge in the treatment and prognosis of the disease. Therefore, the search for new biomarkers of DN is urgent and has important clinical significance for reducing the morbidity and mortality of DN. In this study, two datasets GSE1009 and GSE142153 were selected to extract expression profile-based data from DN glomerular samples, and 238 differentially expressed genes (DEGs) were screened...
August 31, 2023: Cellular and Molecular Biology
https://read.qxmd.com/read/37704455/clinical-significance-of-dna-damage-response-mutations-in-stage-i-and-stage-iiia-nsclc
#27
JOURNAL ARTICLE
Haoran Zhang, Dongming Zhang, Jia Liu, Yuequan Shi, Xiaoyan Liu, Minjiang Chen, Wei Zhong, Jing Zhao, Yan Xu, Mengzhao Wang
BACKGROUND: DNA damage response (DDR) pathways are essential to sustain genomic stability and play a critical role in cancer development and progression. Here, we investigated the profile of DDR gene mutations in early-stage non-small cell lung cancer (NSCLC) and their prognostic values. METHODS: We first examined 74 DDR genes involved in seven DDR pathways and then focused on six specific genes: ATM, BRCA1, BRCA2, CHEK1, BARD1, and BRIP1. A total of 179 stage I and IIIa NSCLC patients who received curative resection in Peking Union Medical College Hospital and their corresponding samples were collected for DNA sequencing, immunohistochemistry and survival analysis...
September 13, 2023: Thoracic Cancer
https://read.qxmd.com/read/37673346/ovarian-high-grade-serous-carcinoma-with-transitional-like-set-morphology-a-homologous-recombination-deficient-tumor
#28
JOURNAL ARTICLE
Emanuela D'Angelo, Iñigo Espinosa, Lara Felicioni, Fiamma Buttitta, Jaime Prat
Thirteen years ago, we pointed out that ovarian transitional cell carcinomas (TCCs) and conventional high-grade serous carcinomas (HGSCs) had similar genetic alterations and clinical behavior. Consequently, ovarian TCC is now classified as a morphologic variant of HGSC. Defective homologous recombination, resulting from genetic or epigenetic inactivation of DNA damage repair genes, such as BRCA1/2, occurs in approximately 50% of the HGSCs. Although BRCA mutations have been associated with HGSCs with solid, pseudoendometrioid or transitional (SET) features, little is known about the role of non-BRCA homologous recombinationrepair (HRR) genes and the HRR status in these tumors...
November 2023: Human Pathology
https://read.qxmd.com/read/37624450/identification-of-six-genes-associated-with-covid-19-related-circadian-rhythm-dysfunction-by-integrated-bioinformatic-analysis
#29
JOURNAL ARTICLE
Yanfeng Xu, Mingyu Zhang, Guanyun Wang, Jigang Yang
Patients with coronavirus disease 2019 (COVID-19) might cause long-term burden of insomnia, while the common pathogenic mechanisms are not elucidated. The gene expression profiles of COVID-19 patients and healthy controls were retrieved from the GEO database, while gene set related with circadian rhythm was obtained from GeneCards database. Seventy-six shared genes were screened and mainly enriched in cell cycle, cell division, and cell proliferation, and 6 hub genes were found out including CCNA2, CCNB1, CDK1, CHEK1, MKI67, and TOP2A, with positive correlation to plasma cells...
August 25, 2023: Functional & Integrative Genomics
https://read.qxmd.com/read/37611378/next-generation-sequencing-reveals-a-high-prevalence-of-pathogenic-mutations-in-homologous-recombination-dna-damage-repair-genes-among-patients-with-uterine-sarcoma
#30
JOURNAL ARTICLE
Dimitrios Nasioudis, Nawar A Latif, Emily M Ko, Lori Cory, Sarah H Kim, Lainie Martin, Fiona Simpkins, Robert Giuntoli
OBJECTIVE: Investigate the incidence of homologous recombination DNA damage response (HR-DDR) genomic alterations among patients with uterine sarcoma. METHODS: The American Association for Cancer Research GENIE v13.0 database was accessed and patients with uterine leiomyosarcoma, adenosarcoma, undifferentiated uterine sarcoma, high-grade endometrial stromal sarcoma, low-grade endometrial stromal sarcoma, and endometrial stromal sarcoma not otherwise specified were identified...
August 21, 2023: Gynecologic Oncology
https://read.qxmd.com/read/37608989/a-unique-gene-signature-predicting-recurrence-free-survival-in-stage-ia-lung-adenocarcinoma
#31
JOURNAL ARTICLE
Shamus R Carr, Haitao Wang, Rasika Hudlikar, Xiaofan Lu, Mary R Zhang, Chuong D Hoang, Fangrong Yan, David S Schrump
OBJECTIVE: Resected stage IA lung adenocarcinoma (LUAD) has a reported 5-year recurrence free survival (RFS) of 63-81%. A unique gene signature stratifying patients with early stage LUAD as high or low-risk of recurrence would be valuable. METHODS: GEO datasets combining European and North American LUAD patients (n=684) were filtered for stage IA (n=105) to develop a robust signature for recurrence (RFSscore). Univariate Cox proportional hazard regression model was used to assess associations of gene expression with RFS and OS...
April 2023: Journal of Thoracic and Cardiovascular Surgery
https://read.qxmd.com/read/37588099/predictive-signature-of-response-to-neoadjuvant-chemotherapy-in-muscle-invasive-bladder-cancer-integrating-mrna-expression-taxonomic-subtypes-and-clinicopathological-features
#32
JOURNAL ARTICLE
Albert Font, Montserrat Domenech, Jose Luis Ramirez, Miriam Marqués, Raquel Benítez, Vicenç Ruiz de Porras, José L Gago, Cristina Carrato, Francesc Sant, Hector Lopez, Daniel Castellano, Nuria Malats, M Luz Calle, Francisco X Real
BACKGROUND AND OBJECTIVE: Neoadjuvant chemotherapy (NAC) followed by cystectomy is the standard of care in muscle-invasive bladder cancer (MIBC). Pathological response has been associated with longer survival, but no currently available clinicopathological variables can identify patients likely to respond, highlighting the need for predictive biomarkers. We sought to identify a predictive signature of response to NAC integrating clinical score, taxonomic subtype, and gene expression. MATERIAL AND METHODS: From 1994 to 2014, pre-treatment tumor samples were collected from MIBC patients (stage T2-4N0/+M0) at two Spanish hospitals...
2023: Frontiers in Oncology
https://read.qxmd.com/read/37534654/-application-value-of-whole-exon-sequencing-and-immune-related-indicators-in-the-precision-treatment-of-oral-squamous-cell-carcinoma
#33
JOURNAL ARTICLE
S Xie, Z G Cai, X F Shan
OBJECTIVE: To explore the significance and feasibility of whole exon sequencing and immune related indexes in personalized precision treatment of oral squamous cell carcinoma (OSCC). METHODS: We retrospectively screened the patients who underwent surgery for oral cancer in Peking University Hospital of Stomatology and underwent genetic and immune biomarkers tests between January 2021 and June 2022. Combined with the clinicopathological characteristics of patients, potential targeted drugs and immunotherapy drugs were screened to evaluate the possibility of gene testing benefiting OSCC...
August 18, 2023: Beijing da Xue Xue Bao. Yi Xue Ban, Journal of Peking University. Health Sciences
https://read.qxmd.com/read/37482342/inhibition-of-rrm2-radiosensitizes-glioblastoma-and-uncovers-synthetic-lethality-in-combination-with-targeting-chk1
#34
JOURNAL ARTICLE
Sergio Corrales-Guerrero, Tiantian Cui, Veronica Castro-Aceituno, Linlin Yang, Sindhu Nair, Haihua Feng, Monica Venere, Stephanie Yoon, Todd DeWees, Changxian Shen, Terence M Williams
Glioblastoma (GBM) is an aggressive malignant primary brain tumor. Radioresistance largely contributes to poor clinical outcomes in GBM patients. We targeted ribonucleotide reductase subunit 2 (RRM2) with triapine to radiosensitize GBM. We found RRM2 is associated with increasing tumor grade, is overexpressed in GBM over lower grade gliomas and normal tissue, and is associated with worse survival. We found silencing or inhibition of RRM2 by siRNA or triapine sensitized GBM cells to ionizing radiation (IR) and delayed resolution of IR-induced γ-H2AX nuclear foci...
August 28, 2023: Cancer Letters
https://read.qxmd.com/read/37464398/potential-prognostic-and-therapeutic-value-of-anxa8-in-renal-cell-carcinoma-based-on-the-comprehensive-analysis-of-annexins-family
#35
JOURNAL ARTICLE
Li-Hui Wang, Bo Cao, Yun-Long Li, Bao-Ping Qiao
BACKGROUND: Annexins are a family of proteins involved in a wide variety of cellular processes such as inflammation, proliferation, differentiation, apoptosis, migration and membrane repair. However, the role of most Annexins in renal cell carcinoma (RCC) remained unclear. METHODS: The differentially expressed Annexins in RCC compared with normal controls were screened applying the TCGA database. The correlation of differentially expressed Annexins with clinical stages, grades and overall survival was analyzed to explore the clinical significance of Annexins in RCC...
July 18, 2023: BMC Cancer
https://read.qxmd.com/read/37451671/inhibition-of-checkpoint-kinase-prevents-human-oocyte-apoptosis-induced-by-chemotherapy-and-allows-enhanced-tumour-chemotherapeutic-efficacy
#36
JOURNAL ARTICLE
Meng Wu, Liru Xue, Ying Chen, Weicheng Tang, Yican Guo, Jiaqiang Xiong, Dan Chen, Qingqing Zhu, Fangfang Fu, Shixuan Wang
STUDY QUESTION: Could inhibition of the checkpoint kinase (CHEK) pathway protect human oocytes and even enhance the anti-tumour effects, during chemotherapy? SUMMARY ANSWER: CHEK inhibitors prevented apoptosis of human oocytes induced by chemotherapy and even enhanced the anti-tumour effects. WHAT IS KNOWN ALREADY: CHEK inhibitors showed ovarian protective effects in mice during chemotherapy, while their role in human oocytes is unclear. STUDY DESIGN, SIZE, DURATION: This experimental study evaluated the ovarian reserve of young patients (120 patients) with cancer, exposed or not exposed to taxane and platinum (TP)-combined chemotherapy...
July 14, 2023: Human Reproduction
https://read.qxmd.com/read/37435531/dysfunction-of-ubiquitin-protein-ligase-mycbp2-leads-to-cell-resilience-in-human-breast-cancers
#37
JOURNAL ARTICLE
Ryan A Neff, Almudena Bosch-Gutierrez, Yifei Sun, Igor Katsyv, Won-Min Song, Minghui Wang, Martin J Walsh, Bin Zhang
Breast cancer is the most common type of cancer among women worldwide, and it is estimated that 294 000 new diagnoses and 37 000 deaths will occur each year in the United States alone by 2030. Large-scale genomic studies have identified a number of genetic loci with alterations in breast cancer. However, identification of the genes that are critical for tumorgenicity still remains a challenge. Here, we perform a comprehensive functional multi-omics analysis of somatic mutations in breast cancer and identify previously unknown key regulators of breast cancer tumorgenicity...
September 2023: NAR cancer
https://read.qxmd.com/read/37418838/lycium-ruthenicum-murr-anthocyanins-inhibit-hyperproliferation-of-synovial-fibroblasts-from-rheumatoid-patients-and-the-mechanism-study-powered-by-network-pharmacology
#38
JOURNAL ARTICLE
Ke Xu, Xinshu Qin, Yi Zhang, Mingyi Yang, Haishi Zheng, Yinglei Li, Xingbin Yang, Qin Xu, Ying Li, Peng Xu, Xingyu Wang
BACKGROUND: Rheumatoid arthritis (RA), is a typical autoimmune disease affecting nearly 1% of the world's population. The dysfunctional hyperproliferation of synovial fibroblast (SF) in articular cartilage of RA patients is considered as the essential etiology. Traditional chemotherapeutic agents for RA treatment are imperfect for their high cost and unpredictable side-effects. L. ruthenicum anthocyanins (LRAC) is a natural product that of potential for therapeutic application against RA...
July 3, 2023: Phytomedicine
https://read.qxmd.com/read/37393021/combined-aurora-kinase-a-and-chk1-inhibition-enhances-radiosensitivity-of-triple-negative-breast-cancer%C3%A2-through-induction-of-apoptosis-and-mitotic-catastrophe-associated-with-excessive-dna-damage
#39
JOURNAL ARTICLE
Chunyan Li, Xuanyi Wang, Jiatao Liao, Fei Chen, Xiaomao Guo, Xingxing Chen
PURPOSE: There is an urgent need for biomarkers and new actionable targets to improve radiosensitivity of triple negative breast cancer (TNBC) tumors. In this paper, we characterized the radiosensitizing effects and underlying mechanisms of combined Aurora kinase A (AURKA) and CHK1 inhibition in TNBC. METHODS AND MATERIALS: Different TNBC cell lines were treated with AURKA inhibitor (AURKAi, MLN8237) and CHK1i (CHK1i, MK8776). Cell responses to IR were then evaluated...
June 29, 2023: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/37302522/amt-562-a-novel-her3-targeting-antibody-drug-conjugate-demonstrates-a-potential-to-broaden-therapeutic-opportunities-for-her3-expressing-tumors
#40
JOURNAL ARTICLE
Weining Weng, Tao Meng, Junyi Pu, Linjie Ma, Yi Shen, Zhaohui Wang, Rong Pan, Mingqiao Wang, Caiwei Chen, Lijun Wang, Jianjian Zhang, Biao Zhou, Siyuan Shao, Yu Qian, Shu-Hui Liu, Wenhao Hu, Xun Meng
HER3 is a unique member of the epidermal growth factor receptor family of tyrosine kinases, which is broadly expressed in several cancers, including breast, lung, pancreatic, colorectal, gastric, prostate, and bladder cancers and is often associated with poor patient outcomes and therapeutic resistance. U3-1402/Patritumab-GGFG-DXd is the first successful HER3-targeting ADC molecule with clinical efficacy in non-small cell lung cancer (NSCLC). However, over 60% of patients are non-responsive to U3-1402 due to low target expression levels and responses tend to be in patients with higher target expression levels...
June 11, 2023: Molecular Cancer Therapeutics
keyword
keyword
158724
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.